READING HOSPITAL AND MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $3.5M
- Transactions
- 825
- Companies
- 40
- Average per transaction
- $4,256
Who reported the payments
| Pfizer | $627,759 |
| Novartis | $431,444 |
| Genentech, Inc. | $393,756 |
| Lilly USA, LLC | $367,000 |
| Janssen Research & Development, LLC | $229,044 |
| CSL Behring | $204,932 |
| Arrow International, Inc. | $122,039 |
| AbbVie | $102,178 |
| Beigene, Ltd. | $95,022 |
| Abbott | $90,053 |
| Daiichi Sankyo Inc. | $76,652 |
| Bristol Myers Squibb | $71,990 |
| GSK | $70,655 |
| Impulse Dynamics (USA) Inc. | $60,111 |
| Bayer | $49,442 |
| EMD Serono, Inc. | $39,798 |
| Inspire Medical Systems, Inc. | $35,130 |
| Beone Medicines USA, Inc. | $30,590 |
| E.r. Squibb & Sons, L.L.C. | $27,685 |
| Jazz Pharmaceuticals Inc. | $26,876 |
| Insulet Corporation | $26,125 |
| Siemens Medical Solutions USA, Inc. | $25,257 |
| Astellas Pharma Global Development | $23,646 |
| Aesculap Implant Systems, LLC | $22,000 |
| Amgen | $19,304 |
| Fujirebio Diagnostics, Incorporated | $19,250 |
| Biohaven Pharmaceutical Holding Company Ltd. | $18,311 |
| Gilead | $17,000 |
| Karyopharm Therapeutics Inc. | $15,550 |
| KCI USA, Inc. | $14,700 |
| Incyte Corporation | $12,000 |
| Stryker | $11,582 |
| Applied Medical Resources Corporation | $10,098 |
| Genentech USA, Inc. | $10,000 |
| Viewray Technologies Inc | $10,000 |
| Barco, Inc. | $9,315 |
| Tandem Diabetes Care, Inc. | $8,125 |
| Johnson & Johnson | $7,869 |
| AstraZeneca | $7,511 |
| Mannkind Corporation | $7,500 |